Validation and Psychometric Properties of the Chinese Version of the Transition Expectation Scale in Pediatric Cancer Survivors
Psycho-Oncology · 2026-03 · 35 (3)
DOI: 10.1002/pon.70414 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Psycho-Oncology, online erschienen am 03.03.2026. Verfasst von Jun Ma und 4 weiteren Autor:innen. Beteiligte Einrichtung: Xiangya School of Nursing, Central South University, Changsha, China. Hauptthemen laut MEDLINE: Cancer Survivors, Neoplasms. Die Arbeit nennt 40 Literaturangaben. Gefördert von: the Graduate Students Explore Innovative Programs of Central South University.
Abstract (Originalsprache)
Background
Cancer survivorship begins at diagnosis. Transition expectation is a key modifiable factor that shapes adolescents' movement from adolescence to adult care and is a prerequisite for successful transition and better survival outcomes.
Aims
This study aimed to translate the Transition Expectation Scale (TES) into Chinese (TES‐CN) and address its psychometric properties in pediatric cancer survivors (PCSs).
Methods
We used a two‐phase design. First, the TES was translated and culturally adapted into Chinese in accordance with guidelines. Second, a cross‐sectional psychometric evaluation was conducted in a convenience sample of Chinese PCSs. Reliability and validity were examined.
Results
Two hundred and seventeen PCSs were recruited for psychometric evaluation. The Content validity of the TES‐CN was satisfactory, with a scale‐level content validity index of 0.91 and an item‐level content validity index ranging from 0.78 to 1.00. Exploratory and confirmatory factor analyses supported an 11‐item, three‐factor structure explaining 64.3% of the variance. Compared to the original single‐factor structure, the three‐factor model demonstrated a better fit (Δχ 2 = 116.58, Δdf = 13, p < 0.001). The convergent and discriminant validity results also jointly indicated that the three constructs were empirically distinct, and the model exhibited satisfactory construct validity. The TES‐CN had good reliability, with a Cronbach's alpha of 0.89 and test–retest coefficients ranging from 0.60 to 0.94, indicating acceptable to excellent temporal stability.
Conclusions
The TES‐CN is a reliable and valid tool for assessing transition expectations among Chinese PCSs and can be used in Chinese research and clinical settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Xiangya School of Nursing, Central South University, Changsha, China.
- Department of Obstetrical Nursing, West China Second University Hospital, Sichuan University, Chengdu, China.
- Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, China.
- Mobile Health Ministry of Education-China Mobile Joint Laboratory, Xiangya Hospital, Central South University, Changsha, China.
- Nursing and Materials Medical Engineering Interdisciplinary Research Laboratory, West China Hospital, Sichuan University, Chengdu, China.
- Health Management Center, Xiangya Hospital, Central South University, Changsha, China.
ORCID-Profile: Jun Ma, Jing Li, Hanif Ullah, Fei Liu
Förderung
- the Graduate Students Explore Innovative Programs of Central South University
Zitieren
APA
Ma, J., Zhang, X., Li, J., Ullah, H., & Liu, F. (2026). Validation and Psychometric Properties of the Chinese Version of the Transition Expectation Scale in Pediatric Cancer Survivors. Psycho-Oncology, 35(3). https://doi.org/10.1002/pon.70414
Vancouver
Ma J, Zhang X, Li J, Ullah H, Liu F. Validation and Psychometric Properties of the Chinese Version of the Transition Expectation Scale in Pediatric Cancer Survivors. Psycho-Oncology. 2026;35(3). doi:10.1002/pon.70414
BibTeX
@article{Ma2026,
author = {Ma, Jun and Zhang, Xia and Li, Jing and Ullah, Hanif and Liu, Fei},
title = {Validation and Psychometric Properties of the Chinese Version of the Transition Expectation Scale in Pediatric Cancer Survivors},
journal = {Psycho-Oncology},
year = {2026},
volume = {35},
number = {3},
doi = {10.1002/pon.70414}
}
EUVIMED